ATHE
Alterity Therapeutics Limited American Depositary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
Alterity Therapeutics (ATHE) Stock: Buy, Sell, or Hold?
$2.10
-0.21 (-9.31%)
▼
5d:
-5.63%
30d:
-25.44%
90d:
-56.26%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (72%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$2.12 – $2.91
Position: OVERSOLD
Forward P/E & Valuation
-2.4x
Next 12M consensus est.
Wall Street Target
$13.25
+532.5% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$2.04 / $3.29
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ATHE shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ATHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ATHE is currently trading at $2.10, which is considered oversold relative to its 30-day fair value range of $2.12 to $2.91.
Technical Outlook: Technically, ATHE is in a strong downtrend. The price is currently testing key support at $2.04. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.3% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.25 (+532.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ATHE is in a strong downtrend. The price is currently testing key support at $2.04. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 9.3% recently.
Market Sentiment: The stock scores a mixed 43/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.25 (+532.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.12 -
$2.91
Company Quality Score
41/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
72.1%
Trading Range & Key Levels
30-Day Trading Range
$2.12 -
$2.91
Current vs Trading Range
OVERSOLD
Support Level
$2.04
Resistance Level
$3.29
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (43/100)
- BEARISH: Downward momentum (-9.3%)
- BULLISH: Trading 532.5% below Wall St target ($13.25)
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.35
Wall Street Target
$13.25
(+532.5%)
Revenue Growth (YoY)
-79.0%
Share ATHE Analysis
Share this live ATHE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ATHE)
Bearish
1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Jan 21, 2022
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on ATHE are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:34 PM ET
Data refreshes hourly during market hours. Next update: 8:34 PM
Data refreshes hourly during market hours. Next update: 8:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$302 | 51 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
STRONG BUY
32 analysts |
$592 | 39 SELL |
|
ONC
BeOne Medicines AG |
STRONG BUY
27 analysts |
$438 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$304 | 36 SELL |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
15 analysts |
$22 | 67 BUY |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ATHE Research Pages
